resiquimod has been researched along with promethazine in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (promethazine) | Trials (promethazine) | Recent Studies (post-2010) (promethazine) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 3,110 | 299 | 235 |
| Protein | Taxonomy | resiquimod (IC50) | promethazine (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 5.86 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 5.86 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 5.86 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.012 | |
| Procathepsin L | Homo sapiens (human) | 5.86 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 4.238 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.035 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0076 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0046 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.681 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 5.86 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 5.86 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5.86 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 5.86 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.014 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.4395 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.053 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 2.431 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.596 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.02 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.744 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 4.238 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.165 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.183 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.045 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.012 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.596 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.8 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0041 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.559 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.068 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.429 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 5.86 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.287 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 5.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for resiquimod and promethazine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |